Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia is a research paper published in American Journal of Hematology (2021). On theSindex it has a DataRank of 0. It has been cited 55 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: MD Anderson Cancer Center Support Grant CA016672; Pfizer
NCI NIH HHS
Grant: P30 CA016672
MeSH Terms